Stockreport

Assessing Annexon (ANNX) Valuation After EMA Filing For Tanruprubart In Guillain Barre Syndrome [Yahoo! Finance]

Annexon, Inc. - common stock  (ANNX) 
PDF Annexon (ANNX) is back in focus after the company submitted a Marketing Authorization Application to the European Medicines Agency for tanruprubart in Guillain Barre sy [Read more]